Your browser doesn't support javascript.
loading
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Myers, Andrea P; Konstantinopoulos, Panagiotis A; Barry, William T; Luo, Weixiu; Broaddus, Russell R; Makker, Vicky; Drapkin, Ronny; Liu, Joyce; Doyle, Austin; Horowitz, Neil S; Meric-Bernstam, Funda; Birrer, Michael; Aghajanian, Carol; Coleman, Robert L; Mills, Gordon B; Cantley, Lewis C; Matulonis, Ursula A; Westin, Shannon N.
Afiliación
  • Myers AP; Division of Hematology/Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Konstantinopoulos PA; Division of Hematology/Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Barry WT; University of Pennsylvania, Philadelphia, PA.
  • Luo W; Division of Hematology/Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Broaddus RR; Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX.
  • Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.
  • Drapkin R; Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA.
  • Liu J; Division of Hematology/Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Doyle A; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.
  • Horowitz NS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Dana Farber Cancer Institute, Boston, MA.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX.
  • Birrer M; Division of Medical Oncology, Massachusetts General Hospital, Boston, MA.
  • Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX.
  • Mills GB; Department of Systems Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX.
  • Cantley LC; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Matulonis UA; Division of Hematology/Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX.
Int J Cancer ; 147(2): 413-422, 2020 07 15.
Article en En | MEDLINE | ID: mdl-31714586
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Fosfatidilinositol 3-Quinasa Clase I / Compuestos Heterocíclicos con 3 Anillos / Mutación / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Fosfatidilinositol 3-Quinasa Clase I / Compuestos Heterocíclicos con 3 Anillos / Mutación / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Marruecos